Autolus Therapeutics
AUTL
#7442
Rank
ยฃ0.31 B
Marketcap
ยฃ1.19
Share price
2.58%
Change (1 day)
-48.45%
Change (1 year)

Revenue for Autolus Therapeutics (AUTL)

Revenue in 2025 (TTM): ยฃ37.97 Million

According to Autolus Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ38.35 Million. In 2024 the company made a revenue of ยฃ8.06 Million an increase over the revenue in the year 2023 that were of ยฃ1.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Autolus Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ37.97 M370.94%
2024 ยฃ8.06 M505.06%
2023 ยฃ1.33 M-73.97%
2022 ยฃ5.11 M358.59%
2021 ยฃ1.11 M528.83%
2020 ยฃ0.17 M-89.76%
2019 ยฃ1.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA